Toleranzia Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

Toleranzia General Information

Description

Developer of biotechnology intended to treat autoimmune orphan diseases. The company's technology utilizes a proprietary platform to restore immunological tolerance and target underlying disease causes, providing pharmaceutical partners with drug candidates for neuromuscular and blood vessel conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Arvid Wallgrens backe 20, 8 Trappor
  • 413 46 Gothenburg
  • Sweden
+46 076-319
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Arvid Wallgrens backe 20, 8 Trappor
  • 413 46 Gothenburg
  • Sweden
+46 076-319

Toleranzia Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Toleranzia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Toleranzia‘s full profile, request access.

Request a free trial

Toleranzia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotechnology intended to treat autoimmune orphan diseases. The company's technology utilizes a proprietary
Drug Discovery
Gothenburg, Sweden
10 As of 2025

Antwerp, Belgium
 

King Of Prussia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Toleranzia Competitors (46)

One of Toleranzia’s 46 competitors is Agomab Therapeutics, a Formerly VC-backed company based in Antwerp, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agomab Therapeutics Formerly VC-backed Antwerp, Belgium
CSL Behring Corporation King Of Prussia, PA
Baliopharm Venture Capital-Backed Basel, Switzerland
Prothena Corporation Dublin, Ireland
Prevail Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 46 competitors. Get the full list »

Toleranzia Patents

Toleranzia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024186255-A1 Combination treatment of autoimmune disease, comprising acetylcholine receptor peptide Inactive 09-Mar-2023
US-20240270816-A1 Fusion protein for treating myasthenia gravis Pending 07-Jun-2021
WO-2022260579-A3 Fusion protein for treating myasthenia gravis Inactive 07-Jun-2021
WO-2022260579-A2 Fusion protein in myasthenia gravis Inactive 07-Jun-2021
WO-2013160865-A1 Immunotolerizing fusion proteins for treatment of multiple sclerosis Inactive 26-Apr-2012 A61K39/0007
To view Toleranzia’s complete patent history, request access »

Toleranzia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Toleranzia Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Toleranzia‘s full profile, request access.

Request a free trial

Toleranzia FAQs

  • When was Toleranzia founded?

    Toleranzia was founded in 2011.

  • Where is Toleranzia headquartered?

    Toleranzia is headquartered in Gothenburg, Sweden.

  • What is the size of Toleranzia?

    Toleranzia has 10 total employees.

  • What industry is Toleranzia in?

    Toleranzia’s primary industry is Drug Discovery.

  • Is Toleranzia a private or public company?

    Toleranzia is a Private company.

  • What is Toleranzia’s current revenue?

    The current revenue for Toleranzia is .

  • How much funding has Toleranzia raised over time?

    Toleranzia has raised $2.52M.

  • Who are Toleranzia’s investors?

    Flerie has invested in Toleranzia.

  • Who are Toleranzia’s competitors?

    Agomab Therapeutics, CSL Behring, Baliopharm, Prothena, and Prevail Therapeutics are some of the 46 competitors of Toleranzia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process